RNA expression analysis from formalin fixed paraffin embedded tissues

SM Farragher, A Tanney, RD Kennedy… - Histochemistry and cell …, 2008 - Springer
Formalin fixation and paraffin embedding (FFPE) is the most commonly used method
worldwide for tissue storage. This method preserves the tissue integrity but causes extensive …

[HTML][HTML] The enigmatic HOX genes: can we crack their code?

Z Luo, SK Rhie, PJ Farnham - Cancers, 2019 - mdpi.com
Homeobox genes (HOX) are a large family of transcription factors that direct the formation of
many body structures during early embryonic development. There are 39 genes in the …

[HTML][HTML] Discovery and validation of a prostate cancer genomic classifier that predicts early metastasis following radical prostatectomy

N Erho, A Crisan, IA Vergara, AP Mitra, M Ghadessi… - PloS one, 2013 - journals.plos.org
Purpose Clinicopathologic features and biochemical recurrence are sensitive, but not
specific, predictors of metastatic disease and lethal prostate cancer. We hypothesize that a …

[HTML][HTML] Development and validation of a 28-gene hypoxia-related prognostic signature for localized prostate cancer

L Yang, D Roberts, M Takhar, N Erho, BAS Bibby… - …, 2018 - thelancet.com
Background Hypoxia is associated with a poor prognosis in prostate cancer. This work
aimed to derive and validate a hypoxia-related mRNA signature for localized prostate …

[HTML][HTML] A tissue biomarker panel predicting systemic progression after PSA recurrence post-definitive prostate cancer therapy

T Nakagawa, TM Kollmeyer, BW Morlan, SK Anderson… - PloS one, 2008 - journals.plos.org
Background Many men develop a rising PSA after initial therapy for prostate cancer. While
some of these men will develop a local or metastatic recurrence that warrants further …

[HTML][HTML] mRNA expression signature of Gleason grade predicts lethal prostate cancer

KL Penney, JA Sinnott, K Fall, Y Pawitan… - Journal of Clinical …, 2011 - ncbi.nlm.nih.gov
Purpose Prostate-specific antigen screening has led to enormous overtreatment of prostate
cancer because of the inability to distinguish potentially lethal disease at diagnosis. We …

Atypical metastases from prostate cancer: 10-year experience at a single institution

AH Vinjamoori, JP Jagannathan… - American journal of …, 2012 - Am Roentgen Ray Soc
OBJECTIVE. The purpose of the study was to retrospectively review the frequency, sites, and
patterns of atypical metastases from prostate cancer and to determine whether any …

RHAMM (CD168) is overexpressed at the protein level and may constitute an immunogenic antigen in advanced prostate cancer disease

KM Gust, MD Hofer, SR Perner, R Kim, AM Chinnaiyan… - Neoplasia, 2009 - Elsevier
Localized prostate cancer (CaP) can be cured using several strategies. However, the need
to identify active substances in advanced tumor stages is tremendous, as the outcome in …

Stromal gene expression is predictive for metastatic primary prostate cancer

F Mo, D Lin, M Takhar, VR Ramnarine, X Dong… - European urology, 2018 - Elsevier
Background Clinical grading systems using clinical features alongside nomograms lack
precision in guiding treatment decisions in prostate cancer (PCa). There is a critical need for …

[HTML][HTML] LNCaP Atlas: Gene expression associated with in vivoprogression to castration-recurrent prostate cancer

TL Romanuik, G Wang, O Morozova, A Delaney… - BMC medical …, 2010 - Springer
Background There is no cure for castration-recurrent prostate cancer (CRPC) and the
mechanisms underlying this stage of the disease are unknown. Methods We analyzed the …